Determination of the most informative prognostic parameters for assessing the status of the epidermal growth factor receptor Her2/neu in the primary tumor in breast cancer patients using the targeted radiopharmaceutical «99mTc-ADAPT6». Вопр. онкол. [Internet]. 2021 Jul. 6 [cited 2026 Oct. 14];67(3):368-73. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1203